Lv5
830 积分 2024-09-06 加入
High pathological response rate after neoadjuvant immunotherapy in locally advanced mismatch repair-deficient colon cancer (NICHE-2 study)
4小时前
待确认
Neoadjuvant immune checkpoint inhibition in locally advanced MMR-deficient colon cancer: the NICHE-2 study
4小时前
求助中
PRDM1 promotes the ferroptosis and immune escape of thyroid cancer by regulating USP15-mediated SELENBP1 deubiquitination
1个月前
已完结
SBP1 promotes tumorigenesis of thyroid cancer through TXN/NIS pathway
2个月前
已完结
Expression of selenium‐binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer
2个月前
已完结
EZH2 suppresses IR-induced ferroptosis by forming a co-repressor complex with HIF-1α to inhibit ACSL4: Targeting EZH2 enhances radiosensitivity in KDM6A-deficient esophageal squamous carcinoma
2个月前
已完结
Cyclopeptide RA-V from Rubia yunnanensis restores activity of Adagrasib against colorectal cancer by reducing the expression of Nrf2
7个月前
已完结
Prognostic value of specific KRAS mutations in patients with colorectal peritoneal metastases
7个月前
已完结
Increased KRAS G12C Prevalence, High Tumor Mutational Burden, and Specific Mutational Signatures Are Associated With MUTYH Mutations: A Pan-Cancer Analysis
7个月前
已完结
Another KRAS Inhibitor Holds Its Own
7个月前
已关闭
皖公网安备34019202002308
